perfosfamide has been researched along with Cancer of Ovary in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (40.00) | 18.7374 |
| 1990's | 3 (60.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Teufel, G | 1 |
| Crown, JP; Kritz, A; Moore, MA; Norton, L; Reich, L; Schneider, JG; Wasserheit, C; Wong, G | 1 |
| Bast, RC; Lidor, YJ; Peters, WP; Shpall, EJ | 1 |
| Lee, FY | 1 |
| Berens, ME; Modest, EJ; Noseda, A; White, JG | 1 |
1 trial(s) available for perfosfamide and Cancer of Ovary
| Article | Year |
|---|---|
Factors affecting the mobilization of primitive and committed hematopoietic progenitors into the peripheral blood of cancer patients.
Topics: Adult; Antigens, CD; Antigens, CD34; Blood Cells; Bone Marrow Cells; Bone Marrow Transplantation; Breast Neoplasms; Cell Separation; Combined Modality Therapy; Cyclophosphamide; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Hematopoiesis; Hematopoietic Cell Growth Factors; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Humans; Interleukin-1; Middle Aged; Ovarian Neoplasms; Stem Cell Factor | 1994 |
4 other study(ies) available for perfosfamide and Cancer of Ovary
| Article | Year |
|---|---|
[Experiences with Volm's short-term tumor test in the primary treatment of ovarian carcinoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Cell Division; Cells, Cultured; Cisplatin; Cyclophosphamide; Doxorubicin; Drug Resistance; Female; Fluorouracil; Humans; Ovarian Neoplasms; Prognosis; Thymidine; Uridine | 1984 |
Synergistic cytotoxicity of different alkylating agents for epithelial ovarian cancer.
Topics: Alkylating Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Cell Division; Cisplatin; Cyclophosphamide; Drug Synergism; Female; Humans; Melphalan; Ovarian Neoplasms; Thiotepa; Tumor Cells, Cultured | 1991 |
Glutathione diminishes the anti-tumour activity of 4-hydroperoxycyclophosphamide by stabilising its spontaneous breakdown to alkylating metabolites.
Topics: Alkylating Agents; Animals; Antimetabolites; Buthionine Sulfoximine; Cyclophosphamide; Drug Synergism; Female; Glutathione; Humans; Intracellular Fluid; Kinetics; Methionine Sulfoximine; Mice; Mice, Inbred Strains; Ovarian Neoplasms; Tumor Cells, Cultured | 1991 |
In vitro antiproliferative activity of combinations of ether lipid analogues and DNA-interactive agents against human tumor cells.
Topics: Adenocarcinoma; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cell Division; Cell Survival; Cisplatin; Cyclophosphamide; Doxorubicin; Female; In Vitro Techniques; Ovarian Neoplasms; Phospholipid Ethers; Piperidines; Tumor Cells, Cultured | 1988 |